Share Email Print
cover

Proceedings Paper

Investigation of therapeutics width in treatment of experimental cancer used by the model of medicine based on photosensitizer of second generation for PDT--aluminum sulfonated phthalocyanine
Author(s): Victor E. Normansky; Maria G. Galpern
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Width of the therapeutic action of a drug model on the basis of aluminum sylphonated phthalocyanine -- photosensitizer of the second generation for PDT -- was investigated on laboratory mice with spontaneous breast tumor. Three general types of tumors were investigated in the process of morphological investigation: pleomorphic adenocarcinomas of type A and B, and monomorphic adenocarcinomas of type C. Different tumors local selectivity to the present photosensitizer was established by the microspectrofluorimetric method. The largest tumor accumulation selectivity, and also photosensitizer distribution uniformity, were revealed in a high-differentiation variant of pleomorphic adenocarcinomas of type B, which is more sensitive to PDT. It was experimentally determined that the combination of surface and interstitial irradiation is necessary in the overwhelming majority of cases.

Paper Details

Date Published: 1 March 1994
PDF: 4 pages
Proc. SPIE 2078, Photodynamic Therapy of Cancer, (1 March 1994); doi: 10.1117/12.168703
Show Author Affiliations
Victor E. Normansky, Organic Intermediates and Dyes Institute (Russia)
Maria G. Galpern, Organic Intermediates and Dyes Institute (Russia)


Published in SPIE Proceedings Vol. 2078:
Photodynamic Therapy of Cancer
Giulio Jori; Johan Moan; Willem M. Star, Editor(s)

© SPIE. Terms of Use
Back to Top